scholarly journals Proximal extent of pelvic vein thrombosis and its association with pulmonary embolism

2003 ◽  
Vol 37 (3) ◽  
pp. 518-522 ◽  
Author(s):  
Barbara Borst-Krafek ◽  
Astrid Maria Fink ◽  
Claudia Lipp ◽  
Helmut Umek ◽  
Horst Köhn ◽  
...  
2011 ◽  
Vol 2011 ◽  
pp. 1-3 ◽  
Author(s):  
Gina Elhammady ◽  
Andrew T. Schubeck ◽  
Vicky El-Najjar ◽  
Morton J. Robinson

Periprostatic or paravaginal venous thromboses are rarely considered clinically as sites of clot origin in patients with pulmonary thromboembolism. The majority of emboli have been demonstrated to originate in the veins of the legs. This report raises awareness of pelvic vein thrombosis as a potential source of pulmonary embolism that is rarely considered or detected clinically, and which usually requires postmortem examination for recognition. It also reviews the possible routes emboli may take to reach the lungs.


1984 ◽  
Vol 149 (7) ◽  
pp. 796-798 ◽  
Author(s):  
Daniel L. Clarke-Pearson ◽  
R.Edward Coleman ◽  
Neil Petry ◽  
Ingrid S. Synan ◽  
William T. Creasman

1992 ◽  
Vol 16 (5) ◽  
pp. 0715-0722 ◽  
Author(s):  
H. Brownell Wheeler ◽  
Hugo Brownell Partsch ◽  
Karin Brownell Oburger ◽  
Adolf Brownell Mostbeck ◽  
Beatrix Brownell K[ouml ]nig

1992 ◽  
Vol 16 (5) ◽  
pp. 715-722 ◽  
Author(s):  
Hugo Partsch ◽  
Karin Oburger ◽  
Adolf Mostbeck ◽  
Beatrix König ◽  
Horst Köhn

VASA ◽  
2007 ◽  
Vol 36 (1) ◽  
pp. 17-22
Author(s):  
Schulz ◽  
Kesselring ◽  
Seeberger ◽  
Andresen

Background: Patients admitted to hospital for surgery or acute medical illnesses have a high risk for venous thromboembolism (VTE). Today’s widespread use of low molecular weight heparins (LMWH) for VTE prophylaxis is supposed to have reduced VTE rates substantially. However, data concerning the overall effectiveness of LMWH prophylaxis is sparse. Patients and methods: We prospectively studied all patients with symptomatic and objectively confirmed VTE seen in our hospital over a three year period. Event rates in different wards were analysed and compared. VTE prophylaxis with Enoxaparin was given to all patients at risk during their hospital stay. Results: A total of 50 464 inpatients were treated during the study period. 461 examinations were carried out for symptoms suggestive of VTE and yielded 89 positive results in 85 patients. Seventy eight patients were found to have deep vein thrombosis, 7 had pulmonary embolism, and 4 had both deep venous thrombosis and pulmonary embolism. The overall in hospital VTE event rate was 0.17%. The rate decreased during the study period from 0.22 in year one to 0,16 in year two and 0.13 % in year three. It ranged highest in neurologic and trauma patients (0.32%) and lowest (0.08%) in gynecology-obstetrics. Conclusions: With a simple and strictly applied regimen of prophylaxis with LMWH the overall rate of symptomatic VTE was very low in our hospitalized patients. Beside LMWH prophylaxis, shortening hospital stays and substantial improvements in surgical and anasthesia techniques achieved during the last decades probably play an essential role in decreasing VTE rates.


Sign in / Sign up

Export Citation Format

Share Document